Trimethoprim Tablet
NDC Package 75907-043-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Trimethoprim tablets is trimethoprim is an antibiotic used to treat bacterial infections. This formulation utilizes a tablet delivery system. Marketed by Dr. Reddy's Labratories Inc., this product is identified by NDC 75907-043 and is authorized under FDA application NDA018679.

Identification & Billing

NDC Package Code
75907-043-01
Package Description
100 TABLET in 1 BOTTLE
Product Code
75907-043
11-Digit Billing Format
75907004301
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Trimethoprim
Non-Proprietary Name
Trimethoprim
Substance Name
Trimethoprim
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
TRIMETHOPRIM 100 mg/1
Pharmacologic Class
Usage Information
Trimethoprim is an antibiotic used to treat bacterial infections. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Regulatory & Marketing

Labeler Name
Dr. Reddy's Labratories Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA018679
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
01-30-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 75907-043-01 identifies a specific commercial package of 100 tablet in 1 bottle of Trimethoprim, a human prescription drug labeled by Dr. Reddy's Labratories Inc.. This tablet is formulated for oral use and contains trimethoprim as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dr. Reddy's Labratories Inc. on January 30, 2024. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Trimethoprim is an antibiotic used to treat bacterial infections. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

How is this Dr. Reddy's Labratories Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 75907004301. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
75907-043-01
11-Digit CMS (5-4-2)
75907-0043-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.